Quality of life worsened the most severely in patients immediately after intensity-modulated radiation therapy for prostate cancer

Yasushi Nakai,1 Nobumichi Tanaka,1 Satoshi Anai,1 Makito Miyake,1 Isao Asakawa,2 Yosuke Morizawa,1 Shunta Hori,1 Kazumasa Torimoto,1 Tomomi Fujii,3 Masatoshi Hasegawa,2 Kiyohide Fujimoto1 1Department of Urology, Nara Medical University, Nara, Japan; 2Department of Radiation Oncology, Nara Medical Un...

Full description

Bibliographic Details
Published in:	Research and Reports in Urology
Main Authors:	Nakai Y, Tanaka N, Anai S, Miyake M, Asakawa I, Morizawa Y, Hori S, Torimoto K, Fujii T, Hasegawa M, Fujimoto K
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Subjects:	chronological changes intensity-modulated radiation therapy prostate cancer quality of life radiation therapy
Online Access:	https://www.dovepress.com/quality-of-life-worsened-the-most-severely-in-patients-immediately-aft-peer-reviewed-article-RRU

Similar Items

Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012
by: Nobumichi Tanaka, et al.
Published: (2017-09-01)

Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology
by: William A. Hall, et al.
Published: (2022-09-01)

Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer
by: Naoki Terada, et al.
Published: (2020-11-01)

The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer
by: Kazuyuki Numakura, et al.
Published: (2023-09-01)

CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
by: Michael Waters, et al.
Published: (2024-01-01)

Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer Survivors: The Hidden Toll
by: René Gatsinga, et al.
Published: (2024-10-01)

Consensus Statement on Proton Therapy for Prostate Cancer
by: Curtis M. Bryant, MD, MPH, et al.
Published: (2021-04-01)

Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
by: Makito Miyake, et al.
Published: (2017-08-01)

Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation
by: Vaseem M. Khatri, et al.
Published: (2025-11-01)

Radiation Therapy for Local or Biochemical Recurrence Following Radical Prostatectomy in Patients with Prostate Cancer
by: Nishiyama H, et al.
Published: (2025-09-01)

Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer
by: Alicia Bao, BS, et al.
Published: (2023-05-01)

Twelve-year outcomes of prostate cancer after radical prostatectomy for T3 and/or positive margins managed with surveillance or salvage radiation therapy, based on risk groups
by: Barry W. Goy, et al.
Published: (2021-12-01)

Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer
by: Anusha Muralidhar, et al.
Published: (2023-01-01)

Quality of life of men treated with brachytherapies for prostate cancer
by: Owen Steven V, et al.
Published: (2004-06-01)

Patients with a Short Distance Between the Prostate and the Rectum Are Appropriate Candidates for Hydrogel Spacer Placement to Prevent Short-Term Rectal Hemorrhage After External-Beam Radiotherapy for Prostate Cancer
by: Shunsuke Owa, et al.
Published: (2025-07-01)

Eosinophilic, polymorphic, and pruritic eruption associated with radiation therapy in two patients diagnosed with prostate cancer
by: Maria Alexandra Barbu, et al.
Published: (2023-05-01)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
by: Tae Hoon Lee, et al.
Published: (2023-09-01)

Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
by: Daisuke Gotoh, et al.
Published: (2022-09-01)

Comparison of doublet and triplet therapies for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis
by: Lei Wang, et al.
Published: (2023-03-01)

Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high‐risk localized prostate cancer
by: Ming Yin, et al.
Published: (2020-01-01)

Simulation of an HDR “Boost” with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study
by: Jill S. Remick, MD, et al.
Published: (2020-11-01)

Prospective trial comparing intraoperative flexible, rigid, and no cystoscopy after ultrasound-guided transperineal permanent seed prostate brachytherapy
by: John Sylvester, et al.
Published: (2016-06-01)

Analysis of intra-fractional surface motion during adaptive radiation therapy and relation of internal vs. external position for prostate cancer
by: Fernanda Macedo-Jiménez, et al.
Published: (2025-04-01)

Evaluating the Effects of Prostate Radiotherapy Intensified with Pelvic Nodal Radiotherapy and Androgen Deprivation Therapy on Myelosuppression: Single-Institution Experience
by: Yousef Katib, et al.
Published: (2024-09-01)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
by: Christoph Oehler, et al.
Published: (2022-08-01)

U-Net Architectures for Prostate Cancer Radiation Therapy
by: Bruno Mendes, et al.
Published: (2023-01-01)

Understanding the Impact of Salvage Radiation on the Long‐Term Natural History of Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
by: Spyridon P. Basourakos, et al.
Published: (2025-07-01)

Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
by: Kristiina Vuolukka, et al.
Published: (2020-07-01)

Hospital readmissions for patients with prostate cancer are higher after radiotherapy than after prostatectomy
by: Arshvin Kesavan, et al.
Published: (2022-01-01)

Radiation Oncologists’ Perspectives on Oligometastatic Prostate Cancer: A Survey from Korean Oligometastasis Working Group
by: Gyu Sang Yoo, et al.
Published: (2024-06-01)

Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study
by: Dalia Ahmad Khalil, et al.
Published: (2023-01-01)

Editorial: Advances in radiotherapy for prostate cancer
by: Sophia C. Kamran, et al.
Published: (2022-12-01)

Late radiation-related lymphopenia after prostate stereotactic body radiation therapy plus or minus supplemental pelvic irradiation
by: Kelly Gaudian, et al.
Published: (2024-11-01)

Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)
by: Marshall Diven, et al.
Published: (2024-07-01)

Race‐specific prostate cancer outcomes in a cohort of low and favorable‐intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017
by: Sean P. Stroup, et al.
Published: (2022-12-01)

Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons
by: Matthew Forsthoefel, MD, et al.
Published: (2022-04-01)

A Phase II Trial of SABR (Stereotactic Ablative Body Radiotherapy) for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life and Disease Control Outcomes with 5-Year Minimum Followup
by: Constantine Anastasios Mantz
Published: (2014-11-01)

The Role of Radiation Therapy in the Management of Prostate Cancer and Posttreatment Imaging Appearances
by: Soumyadeep Ghosh, et al.
Published: (2024-09-01)

Response to flutamide, as second-line therapy after bicalutamide, predicts efficacy of abiraterone, not that of enzalutamide
by: Yasushi Nakai, et al.
Published: (2018-05-01)

Passively Scattered Proton Therapy for Nonmelanoma Skin Cancer with Clinical Perineural Invasion
by: Curtis M. Bryant, MD, MPH, et al.
Published: (2021-06-01)